Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
Crossref DOI link: https://0-doi-org.brum.beds.ac.uk/10.1186/s12967-015-0644-4
Published Online: 2015-09-10
Published Print: 2015-12
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/springer_crossmark_policy
Jamieson, Catriona
Hasserjian, Robert
Gotlib, Jason
Cortes, Jorge
Stone, Richard
Talpaz, Moshe
Thiele, Jürgen
Rodig, Scott
Pozdnyakova, Olga